Min Xie
Staff Research Scientist I
Business Service Ctr
Chancellor/EVC/FAS

Publications (6)

Top publication keywords:
Mycobacterium tuberculosisCellular Reprogramming TechniquesSmall Molecule LibrariesTuberculosis, Multidrug-ResistantInduced Pluripotent Stem CellsPluripotent Stem CellsCell TransdifferentiationTuberculosis, PulmonaryRegenerative MedicineCell DifferentiationHigh-Throughput Screening AssaysCell LineageCellular Reprogrammingtau ProteinsDrug Discovery

• Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis.
  Antimicrobial agents and chemotherapy 2021 Ernest JP, Sarathy J, Wang N, Kaya F, Zimmerman MD, Strydom N, Wang H, Xie M, Gengenbacher M, Via LE, Barry CE, Carter CL, Savic RM, Dartois V
• Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
  Stem cell reports 2017 Wang C, Ward ME, Chen R, Liu K, Tracy TE, Chen X, Xie M, Sohn PD, Ludwig C, Meyer-Franke A, Karch CM, Ding S, Gan L
• Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine.
  Cell chemical biology 2016 Liu K, Yu C, Xie M, Li K, Ding S
• Conversion of human fibroblasts into functional cardiomyocytes by small molecules.
  Science (New York, N.Y.) 2016 Cao N, Huang Y, Zheng J, Spencer CI, Zhang Y, Fu JD, Nie B, Xie M, Zhang M, Wang H, Ma T, Xu T, Shi G, Srivastava D, Ding S
• Concise review: chemical approaches for modulating lineage-specific stem cells and progenitors.
  Stem cells translational medicine 2013 Xu T, Zhang M, Laurent T, Xie M, Ding S
• Progress in the reprogramming of somatic cells.
  Circulation research 2013 Ma T, Xie M, Laurent T, Ding S